Biochemical evaluation of the renin-angiotensin system: The good, bad, and absolute?

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 310, Issue 2, 2016, Pages H137-H152

  Chappell, Mark C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

ACE; Angiotensin; Heart; Renin

Indexed keywords

AMINOPEPTIDASE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSINOGEN; ANGIOTENSIN[1-7]; CHYMASE; DIPEPTIDYL CARBOXYPEPTIDASE; PROLYL ENDOPEPTIDASE; PROTEINASE; RAS PROTEIN; THIMET OLIGOPEPTIDASE; BIOLOGICAL MARKER;

BIOCHEMICAL ANALYSIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CELL GROWTH; CIRCULATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROSIS; FLUID INTAKE; HUMAN; INFLAMMATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM RETENTION; URINE; VASOCONSTRICTION; ANIMAL; BLOOD PRESSURE; HEART DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BIOMARKERS; BLOOD PRESSURE; HEART DISEASES; HUMANS; RENIN-ANGIOTENSIN SYSTEM;

EID: 84954503383     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00618.2015     Document Type: Review

References (152)

1. Abadir PM, Foster DB, Crow M, Cooke CA, Rucker JJ, Jain A, Smith BJ, Burks TN, Cohn RD, Fedarko NS, Carey RM, O’Rourke B, Walston JD. Identification and characterization of a functional mitochondrial angiotensin system. Proc Natl Acad Sci USA 108: 14849-14854, 2011
2. Abadir PM, Walston JD, Carey RM. Subcellular characteristics of functional intracellular renin-angiotensin systems. Peptides 38: 437-445, 2012
3. Ahmad S, Simmons T, Varagic J, Moniwa N, Chappell MC, Ferrario CM. Chymase-dependent generation of angiotensin II from angiotensin- (1-12) in human atrial tissue. PLoS One 6: e28501, 2011
4. Albiston AL, Fernando RN, Yeatman HR, Burns P, Ng L, Daswani D, Diwakarla S, Pham V, Chai SY. Gene knockout of insulin-regulated aminopeptidase: loss of the specific binding site for angiotensin IV and age-related deficit in spatial memory. Neurobiol Learn Mem 93: 19-30, 2010
5. Alge JL, Karakala N, Neely BA, Janech MG, Tumlin JA, Chawla LS, Shaw AD, Arthur JM. Association of elevated urinary concentration of renin-angiotensin system components and severe AKI. Clin J Am Soc Nephrol 8: 2043-2052, 2013
6. Alghamri MS, Morris M, Meszaros JG, Elased KM, Grobe N. Novel role of aminopeptidase-A in angiotensin-(1-7) metabolism post myocardial infarction. Am J Physiol Heart Circ Physiol 306: H1032-H1040, 2014
7. Ali Q, Wu Y, Nag S, Hussain T. Estimation of angiotensin peptides in biological samples by LC/MS method. Anal Methods 6: 215-222, 2014
8. Ali Q, Wu Y, Hussain T. Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats. Kidney Int 84: 931-939, 2013
9. Alzayadneh EM, Chappell MC. Angiotensin-(1-7) abolishes AGEinduced cellular hypertrophy and myofibroblast transformation via inhibition of ERK1/2. Cell Signal 26: 3027-3035, 2014
10. Alzayadneh EM, Chappell MC. Nuclear expression of renin-angiotensin system components in NRK-52E renal epithelial cells. J Renin Angiotensin Aldosterone Syst. 2014 Jun 24. pii: 1470320313515039. [Epub ahead of print]
11. Anderson NL, Anderson NG. The human proteonome. Mol Cell Proteonomics 1: 845-867, 2002
12. Bader M, Alenina N, Andrade-Navarro MA, Santos RA. MAS and its related G protein-coupled receptors, Mrgprs. Pharmacol Rev 66: 1080-1105, 2014
13. Baker M. Reproducibility crisis: blame it on the antibodies. Nature 521: 274-276, 2015
14. Balcells E, Meng QC, Hageman GR, Palmer RW, Durand JN, Dell’Italia LJ. Angiotensin II formation in dog heart is mediated by different pathways in vivo and in vitro. Am J Physiol 40: H417-H421, 1996
15. Bernstein KE, Ong FS, Blackwell WL, Shah KH, Giani JF, Gonzalez- Villalobos RA, Shen XZ, Fuchs S, Touyz RM. A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme. Pharmacol Rev 65: 1-46, 2013
16. Bertoncello N, Moreria RP, Arita DY, Aragao DS, Watanabe IKM, Dantas PS, Santos R, Mattar-Rosa R, Yokota R, Cunha TS, Casarini DE. Diabetic nephropathy induced by Ace gene dosage is associated with high renal levels of angiotensin-(1-7) and bradykinin. J Diabetes Res 67: 1-13, 2015
17. + exchanger in nuclear membranes of heart, hepatic, vascular endothelial, and smooth muscle cells. Can J Physiol Pharmacol 84: 431-441, 2006
18. Bodineau L, Frugiere A, Marc Y, Inguimbert N, Fassot C, Balavoine F, Roques B, Llorens-Cortes C. Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension. Hypertension 51: 1318-1325, 2008
19. Burger D, Reudelhuber TL, Mahajan A, Chibale K, Sturrock ED, Touyz RM. Effects of a domain-selective ACE inhibitor in a mouse model of chronic angiotensin II-dependent hypertension. Clin Sci (Lond) 127: 57-63, 2014
20. Camenzind AG, van der Gugten JG, Popp R, Holmes DT, Borchers CH. Development and evaluation of an immuno-MALDI (iMALDI) assay for angiotensin I and the diagnosis of secondary hypertension. Clin Proteomics 10: 20, 2013
21. Campbell DJ. Angiotensin II generation in vivo: does it involve enzymes other than renin and angiotensin-converting enzyme? J Renin Angiotensin Aldosterone Syst 13: 314-316, 2012
22. Campbell DJ, Duncan AM, Kladis A, Harrap SB. Angiotensin peptides in spontaneously hypertensive and normotensive donryu rats. Hypertension 25: 928-934, 1995
23. Campbell DJ, Kladis A, Duncan AM. Nephrectomy, converting enzyme inhibition and angiotensin peptides. Hypertension 22: 513-522, 1993
24. Campbell DJ, Alexiou T, Xiao HD, Fuchs S, McKinley MJ, Corvol P, Bernstein KE. Effect of reduced ACE gene expression and ACE inhibition on angiotensin and bradykinin peptide levels in mice. Hypertension 43: 854-859, 2004
25. Carey RM. Functional intracellular renin-angiotensin systems: potential for pathophysiology of disease. Am J Physiol Regul Integr Comp Physiol 302: R479-R481, 2012
26. Castro-Moreno P, Pardo JP, Henandez-Munoz R, Lopez-Guerrero JJ, Valle-Mondragon LD, Pastelin-Hernandez G, Ibarra-Barajas M, Vilalobos-Molina R. Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR. Auton Autacoid Pharmacol 32: 61-69, 2012
27. Caughey GH, Raymond WW, Wolters PJ. Angiotensin II generation by mast cell alpha- and beta-chymases. Biochim Biophys Acta 1480: 245-257, 2000
28. Caughey GH. Mast cell proteases as protective and inflammatory mediators. Adv Exp Med Biol 716: 212-234, 2011
29. Chappell MC. Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7) mas receptor axis; more than regulation of blood pressure? Hypertension 50: 596-599, 2007
30. Chappell MC, Brosnihan KB, Diz DI, Ferrario CM. Identification of angiotensin-(1-7) in rat brain: evidence for differential processing of angiotensin peptides. J Biol Chem 264: 16518-16523, 1989
31. Chappell MC, Gomez MN, Pirro NT, Ferrario CM. Release of angiotensin-(1-7) from the rat hindlimb: influence of angiotensin-converting enzyme inhibition. Hypertension 35: 348-352, 2000
32. Chappell MC, Tallant EA, Brosnihan KB, Ferrario CM. Conversion of angiotensin I to angiotensin-(1-7) by thimet oligopeptidase (EC 3.42415) in vascular smooth muscle cells. J Vasc Med Biol 5: 129-137, 1994
33. Coelho MS, Lpes KL, de Aquino Frietas R, de Oliveira-Sales EB, Bergasmaschi CT, Campos RB, Casarinin DE, Camona AK, da Silva Arauo M., Heimann JC, Dolnikoff MS. High sucrose intake in rats is associated with increased ACE2 and angiotensin-(1-7) levels in adipose tissue. Regul Pept 162: 61-67, 2010
34. Cohen JA, Lindsey SH, Pirro NT, Brosnihan KB, Gallagher PE, Chappell MC. Influence of estrogen depletion and salt loading on renal angiotensinogen expression in the mRen(2). Lewis strain. Am J Physiol Renal Physiol 299: F35-F42, 2010
35. Cook JL, Re RN. Lessons from in vitro studies and a related intracellular angiotensin II transgenic mouse model. Am J Physiol Regul Integr Comp Physiol 302: R482-R493, 2012
36. Dell’Italia LJ, Meng QC, Balcells E, Wei CC, Palmer R, Hageman GR, Durand J, Hankes GH, Oparil S. Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces. J Clin Invest 100: 253-258, 1997
37. DeSilva PE, Husain A, Smeby RR, Khairallah PA. Measurements of immunoreactive angiotensin peptides in rat tissues: some pitfalls in angiotensin II analysis. Anal Biochem 174: 80-87, 1988
38. Durvasula RV, Petermann AT, Hiromura K, Blonski M, Pippin J, Mundel P, Pichler R, Griffin S, Couser WG, Shankland SJ. Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 65: 30-39, 2004
39. Elased KM, Cool DR, Morris M. Novel mass spectrometric methods for evaluation of plasma angiotensin converting enzyme 1 and renin activity. Hypertension 46: 953-959, 2005
40. Ellis B, Li XC, Miguel-Qin E, Gu V, Zhuo JL. Evidence for a functional intracellular angiotensin system in the proximal tubule of the kidney. Am J Physiol Regul Integr Comp Physiol 302: R494-R509, 2012
41. Epelman S, Shrestha K, Troughton RW, Francis GS, Sen S, Klein AL, Tang WH. Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes. J Card Fail 15: 565-571, 2009
42. Fernandes T, Hashimoto NY, Magalhaes FC, Fernandes FB, Casarini DE, Carmona AK, Krieger JE, Phillips MI, Oliveira EM. Aerobic exercise training-induced left ventricular hypertrophy involves regulatory MicroRNAs, decreased angiotensin-converting enzyme-angiotensin ii, and synergistic regulation of angiotensin-converting enzyme 2-angiotensin (1-7). Hypertension 58: 182-189, 2011
43. Ferrario CM. Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation. Hypertension 45: 313-320, 2006
44. Ferrario CM, Jessup JA, Gallagher PE, Averill DB, Brosnihan KB, Tallant EA, Smith RD, Chappell MC. Effects of renin angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors. Kidney Int 68: 2189-2196, 2005
45. Ferrario CM, Martell N, Yunis C, Flack JM, Chappell MC, Brosnihan KB, Dean RH, Fernandez A, Novikov SV, Pinillas C, Luque M. Characterization of angiotensin-(1-7) in the urine of normal and essential hypertensive subjects. Am J Hypertens 11: 137-146, 1998
46. Ferrario CM, Strawn WB. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 98: 121-128, 2006
47. Ferreira AJ, Murça TM, Fraga-Silva RA, Castro CH, Raizada MK, Santos RA. New cardiovascular and pulmonary therapeutic strategies based on the Angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor axis. Int J Hypertens 2012: 147825, 2012
48. Franco MC, Akamine EH, Di Marco GS, Casarini DE, Fortes ZB, Tostes RC, Carvalho MH, Nigro D. NADPH oxidase and enhancedsuperoxide generation in intrauterine undernourished rats: involvement of the renin-angiotensin system. Cardiovasc Res 59: 767-775, 2003
49. Garabelli PJ, Modrall JG, Penninger JM, Ferrario CM, Chappell MC. Distinct roles for angiotensin converting enzyme 2 and carboxypeptidase A in the processing of angiotensins in the murine heart. Exp Physiol 95: 613-621, 2008
50. Gilliam-Davis S, Payne VS, Kasper SO, Tommasi EN, Robbins ME, Diz DI. Long-term AT1 receptor blockade improves metabolic function and provides renoprotection in Fischer-344 rats. Am J Physiol Heart Circ Physiol 293: H1327-H1333, 2007
51. Gomes-Santos IL, Fernandes T, Couto GK, Ferreira-Filho JC, Salemi VM, Fernandes FB, Casarini DE, Brum PC, Rossoni LV, de Oliveira EM, Negrao CE. Effects of exercise training on circulating and skeletal muscle renin-angiotensin system in chronic heart failure rats. PLoS One 9: e98012, 2014
52. Gonzalez AA, Prieto MC. Roles of collecting duct renin and prorenin receptor in hypertension. Ther Adv Cardiovasc Dis 9: 191-200, 2015
53. Grobe N, Elased KM, Cool DR, Morris M. Mass spectrometry for the molecular imaging of angiotensin metabolism in kidney. Am J Physiol Endocrinol Metab 302: E1016-E1024, 2012
54. Gwathmey TM, Alzayadneh EM, Pendergrass KD, Chappell MC. Novel roles of nuclear angiotensin receptors and signaling mechanisms. Am J Physiol Regul Integr Comp Physiol 302: R518-R530, 2012
55. Gwathmey TM, Pendergrass KD, Reid SD, Rose JC, Diz DI, Chappell MC. Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus. Hypertension 55: 166-171, 2010
56. Gwathmey TM, Shaltout HA, Pendergrass KD, Pirro NT, Figueroa JP, Rose JC, Diz DI, Chappell MC. Nuclear angiotensin II type 2 (AT2) receptors are functionally linked to nitric oxide production. Am J Physiol Renal Physiol 296: F1484-F1493, 2009
57. Gwathmey TM, Shaltout HA, Rose JC, Diz DI, Chappell MC. Glucocorticoid-induced fetal programming alters the functional complement of angiotensin receptor subtypes within the kidney. Hypertension 57: 620-626, 2011
58. Gwathmey TM, Westwood BM, Pirro NT, Tang L, Rose JC, Diz DI, Chappell MC. Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide. Am J Physiol Renal Physiol 299: F983-F990, 2010
59. Hafko R, Villapol S, Nostramo R, Symes A, Sabban EL, Inagami T, Saavedra JM. Commercially available angiotensin II At(2) receptor antibodies are nonspecific. PLoS One 8: e69234, 2013
60. Haschke M, Schuster M, Poglitsch M, Loibner H, Salzberg M, Bruggisser M, Penninger J, Krahenbuhl S. Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects. Clin Pharmacokinet 52: 783-792, 2013
61. Herrera M, Sparks MA, Alfonso-Pecchio AR, Harrison-Bernard LM, Coffman TM. Lack of specificity of commercial antibodies leads to misidentification of angiotensin type 1 receptor protein. Hypertension 61: 253-258, 2013
62. Hildebrand D, Merkel P, Eggers LF, Schluter H. Proteolytic processing of angiotensin-I in human blood plasma. PLoS One 8: e64027, 2013
63. Hilgers KF, Bingener E, Stumpf C, Muller DM, Schmieder RE, Veelken R. Angiotensinases restrict locally generated angiotensin II to the blood vessel wall. Hypertension 31: 368-372, 1998
64. Inoue H, Fukui K, Takashi S, Miyake Y. Genetic and molecular properties of the human and rat renin binding protein with reference to the function of the leucine zipper motif. J Biochem 110: 493-500, 1991
65. Ishigami T, Kino T, Chen L, Minegishi S, Araki N, Umemura M, Abe K, Sasaki R, Yamana H, Umemura S. Identification of bona fide alternative renin transcripts expressed along cortical tubules and potential roles in promoting insulin resistance in vivo without significant plasma renin activity elevation. Hypertension 64: 125-133, 2014
66. Jankowski V, Tolle M, Santos RA, Gunthner T, Krause E, Beyermann M, Welker P, Bader M, Pinheiro SV, Sampaio WO, Lautner R, Kretschmer A, van der Giet M, Zidek W, Jankowski J. Angioprotectin: an angiotensin II-like peptide causing vasodilatory effects. FASEB J 25: 2987-2995, 2011
67. Jankowski V, Vanholder R, van der Giet M, Tolle M, Karadogan S, Gobom J, Furkert J, Oksche A, Krause E, Tran TN, Tepel M, Schuchardt M, Schluter H, Wiedon A, Beyermann M, Bader M, Todiras M, Zidek W, Jankowski J. Mass-spectrometric identification of a novel angiotensin peptide in human plasma. Arterioscler Thromb Vasc Biol 27: 297-302, 2007
68. Kemp BA, Bell JF, Rottkamp DM, Howell NL, Shao W, Navar LG, Padia SH, Carey RM. Intrarenal angiotensin III is the predominant agonist for proximal tubule angiotensin type 2 receptors. Hypertension 60: 387-395, 2012
69. Kobori H, Alper AB Jr., Shenava R, Katsurada A, Saito T, Ohashi N, Urushihara M, Miyata K, Satou R, Hamm LL and Navar LG. Urinary angiotensinogen as a novel biomarker of the intrarenal reninangiotensin system status in hypertensive patients. Hypertension 53: 344-350, 2009
70. Kobori H, Katsurada A, Miyata K, Ohashi N, Satou R, Saito T, Hagiwara Y, Miyashita K, Navar LG. Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA. Am J Physiol Renal Physiol 294: F1257-F1263, 2008
71. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59: 251-287, 2007
72. Kobori H, Ohashi N, Katsurada A, Miyata K, Satou R, Saito T, Yamamoto T. Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases. J Am Soc Hypertens 2: 349-354, 2008
73. Kohara K, Tabuchi Y, Senanayake P, Brosnihan KB, Ferrario CM. Reassessment of plasma angiotensins measurement: effects of protease inhibitors and sample handling procedures. Peptides 12: 1135-1141, 1991
74. Kumar R, Thomas CM, Yong QC, Chen W, Baker KM. The intracrine renin-angiotensin system. Clin Sci (Lond) 123: 273-284, 2012
75. Lautner RQ, Villela DC, Fraga-Silva RA, Silva N, Verano-Braga T, Costa-Fraga F, Jankowski J, Jankowski V, Sousa F, Alzamora A, Soares E, Barbosa C, Kjeldsen F, Oliveira A, Braga J, Savergnini S, Maia G, Peluso AB, Passos-Silva D, Ferreira A, Alves F, Martins A, Raizada M, Paula R, Motta-Santos D, Klempin F, Pimenta A, Alenina N, Sinisterra R, Bader M, Campagnole-Santos MJ, Santos RA. Discovery and characterization of alamandine: a novel component of the renin-angiotensin system. Circ Res 112: 1104-1111, 2013
76. Lavoie JL, Liu X, Bianco RA, Beltz TG, Johnson AK, Sigmund CD. Evidence supporting a functional role for intracellular renin in the brain. Hypertension 47: 461-466, 2006
77. Lavrentyev EN, Estes AM, Malik KU. Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells. Circ Res 101: 455-464, 2007
78. Lawrence AC, Evin G, Kladis A, Campbell DJ. An alternative strategy for the radioimmunoassay of angiotensin peptides using amino-terminaldirected antisera: measurement of eight angiotensin peptides in human plasma. J Hypertens 8: 715-724, 1990
79. Lew RA. HPLC in the analysis of peptide metabolism. Methods Mol Biol 251: 275-290, 2004
80. Lew RA, Mustafa T, Ye S, McDowall SG, Chai SY, Albiston AL. Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP). J Neurochem 86: 344-350, 2003
81. Lew RA, Tochon-Danguy N, Hamilton CA, Stewart KM, Aguilar MI, Smith AI. Quenched fluorescent substrate-based peptidase assays. Methods Mol Biol 298: 143-150, 2005
82. Liu L, Gonzalez AA, McCormack M, Seth DM, Kobori H, Navar LG, Prieto MC. Increased renin excretion is associated with augmented urinary angiotensin II levels in chronic angiotensin II-infused hypertensive rats. Am J Physiol Renal Physiol 301: F1195-F1201, 2011
83. Lortie M, Bark S, Blantz R, Hook V. Detecting low-abundance vasoactive peptides in plasma: progress toward absolute quantitation using nano liquid chromatography-mass spectrometry. Anal Biochem 394: 164-170, 2009
84. Lumbers ER, Skinner SL. Origin of renin activity in human urine. Circ Res 24:689-697 1969
85. Mazzolai L, Pedrazzini T, Nicoud F, Gabbiani G, Brunner HR, Nussberger J. Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice. Hypertension 35: 985-991, 2000
86. Miners JS, Verbeek MM, Rikkert MO, Kehoe PG, Love S. Immunocapture- based fluorometric assay for the measurement of neprilysinspecific enzyme activity in brain tissue homogenates and cerebrospinal fluid. J Neurosci Methods 167: 229-236, 2008
87. Mizuno K, Tani M, Niimura S, Hashimoto S, Satoh A, Shimamoto K, Inagami T, Fukuchi S. Direct evidence for local generation and releaseof angiotensin II in human vascular tissue. Biochem Biophys Res Commun 165: 457-463, 1989
88. Modrall JG, Sadjadi J, Brosnihan KB, Gallagher PE, Ya CH, Kramer GL, Bernstein KE, Chappell MC. Depletion of tissue ace differentially influences the intrarenal and urinary expression of angiotensins. Hypertension 43: 4849-4853, 2003
89. Nagata S, Hatakeyama K, Asami M, Tokashiki M, Hibino H, Nishiuchi Y, Kuwasako K, Kato J, Asada Y, Kitamura K. Big angiotensin- 25: a novel glycosylated angiotensin-related peptide isolated from human urine. Biochem Biophys Res Commun 441: 757-762, 2013
90. Nagata S, Kato J, Sasaki K, Minamino N, Eto T, Kitamura K. Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system. Biochem Biophys Res Commun 350: 1026-1031, 2006
91. Navar LG, Imig JD, Zou L, Wang CT. Intrarenal production of angiotensin II. Semin Nephrol 17: 412-422, 1997
92. Navar LG, Kobori H, Prieto MC, Gonzalez-Villalobos RA. Intratubular renin-angiotensin system in hypertension. Hypertension 57: 355-362, 2011
93. Navar LG, Prieto MC, Satou R, Kobori H. Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol 11: 180-186, 2011
94. Nguyen G. Renin/prorenin receptors. Kidney Int 69: 1503-1506, 2006
95. Nishiyama A, Seth DM, Navar LG. Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition. J Am Soc Nephrol 13: 2207-2212, 2002
96. Nishiyama A, Seth DM, Navar LG. Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension 39: 129-134, 2002
97. Nussberger J, Brunner DB, Nyfeler JA, Linder L, Brunner HR. Measurement of immunoreactive angiotensin-(1-7) heptapeptide in human blood. Clin Chem 47: 726-729, 2001
98. Nussberger J, Brunner DB, Waeber B, Brunner HR. True versus immunoreactive angiotensin II in human plasma. Hypertension 7, Suppl 1: I-1-I-7, 1985
99. Nussberger J, Buhler K, Waeber B, Brunner HR. Identification and quantitation of angiotensins. J Cardiovasc Pharmacol 8, Suppl 10: S23-S28, 1986
100. Nussberger J, Wuerzner G, Jensen C, Brunner HR. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril. Hypertension 39: E1-E8, 2002
101. Ocaranza MP, Michea L, Chiong M, Lagos CF, Lavandero S, Jalil JE. Recent insights and therapeutic perspectives of angiotensin-(1-9) in the cardiovascular system. Clin Sci (Lond) 127: 549-557, 2014
102. Olkowicz M, Radulska A, Suraj J, Kij A, Walczak M, Chlopicki S, Smolenski RT. Development of a sensitive, accurate and robust liquid chromatography/mass spectrometric method for profiling of angiotensin peptides in plasma and its application for atherosclerotic mice. J Chromatogr A 1393: 37-46, 2015
103. Padia SH, Kemp BA, Howell NL, Gildea JJ, Keller SR, Carey RM. Intrarenal angiotensin III infusion induces natriuresis and angiotensin type 2 receptor translocation in Wistar-Kyoto but not in spontaneously hypertensive rats. Hypertension 53: 338-343, 2009
104. Pendergrass KD, Averill DB, Ferrario CM, Diz DI, Chappell MC. Differential expression of nuclear AT1 receptors and angiotensin II within the kidney of the male congenic mRen2. Lewis rat. Am J Physiol Renal Physiol 290: F1497-F1506, 2006
105. Pendergrass KD, Gwathmey TM, Michalek RD, Grayson JM, Chappell MC. The angiotensin II-AT1 receptor stimulates reactive oxygen species within the cell nucleus. Biochem Biophys Res Commun 384: 149-154, 2009
106. Peters J, Clausmeyer S. Intracellular sorting of renin: cell type specific differences and their consequences. J Mol Cell Cardiol 34: 1561-1568, 2002
107. Peters J, Wanka H, Peters B, Hoffmann S. A renin transcript lacking exon 1 encodes for a non-secretory intracellular renin that increases aldosterone production in transgenic rats. J Cell Mol Med 12: 1229-1237, 2008
108. Poglitsch M, Domenig O, Schwager C, Stranner S, Peball B, Janzek E, Wagner B, Jungwirth H, Loibner H, Schuster M. Recombinant expression and characterization of human and murine ACE2: Speciesspecific activation of the alternative renin-angiotensin-System. Int J Hypertens 2012: 428950, 2012
109. Reaux-Le GA, Iturrioz X, Fassot C, Claperon C, Roques BP, Llorens- Cortes C. Role of angiotensin III in hypertension. Curr Hypertens Rep 7: 128-134, 2005
110. Ribeiro AA, Palomino Z, Lima MP, Souza LE, Ferreira DS, Pesquero JB, Irigoyen MC, Pesquero JL, Casarini DE. Characterization of the renal renin-angiotensin system in transgenic mice that express rat tonin. J Renin Angiotensin Aldosterone Syst. 2015 Jul 27. pii: 1470320315595572. [Epub ahead of print]
111. Rice GI, Jones AL, Grant PJ, Carter AM, Turner AJ, Hooper NM. Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study. Hypertension 48: 914-920, 2006
112. Rice GI, Thomas DA, Grant PJ, Turner AJ, Hooper NM. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 383: 45-51, 2004
113. Roksnoer LC, Verdonk K, van den Meiracker AH, Hoorn EJ, Zietse R, Danser AH. Urinary markers of intrarenal renin-angiotensin system activity in vivo. Curr Hypertens Rep 15: 81-88, 2013
114. Ronchi FA, Irigoyen MC, Casarini DE. Association of somatic and N-domain angiotensin-converting enzymes from Wistar rat tissue with renal dysfunction in diabetes mellitus. J Renin Angiotensin Aldosterone Syst 8: 34-41, 2007
115. Rubio-Ruiz ME, Del Valle-Mondragon L, Castregjon-Tellez V, Carreon-Torees E, Diaz-Diaz E, Guarner-Lans V. Angiotensin II and 1-7 during aging in metabolic syndrome rats Expression of AT1 and AT2 and Mas receptors in abdominal white adipose tissue. Peptides 57: 101-108, 2014
116. Rykl J, Thiemann J, Kurzawski S, Pohl T, Gobom J, Zidek W, Schluter H. Renal cathepsin G and angiotensin II generation. J Hypertens 24: 1797-1807, 2006
117. Santos CF, Caprio MA, Oliveira EB, Salgado MC, Schippers DN, Munzenmaier DH, Greene AS. Functional role, cellular source, and tissue distribution of rat elastase-2, an angiotensin II-forming enzyme. Am J Physiol Heart Circ Physiol 285: H775-H783, 2003
118. Santos CF, Greene AS, Salgado MC, Oliveira EB. Conversion of renin substrate tetradecapeptide to angiotensin II by rat MAB elastase-2. Can J Physiol Pharmacol 82: 1000-1005, 2004
119. Santos RA. Angiotensin-(1-7). Hypertension 63: 1138-114, 2014
120. Santos RA, Ferreira AJ, Verano-Braga T, Bader M. Angiotensinconverting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system. J Endocrinol 216: R1-R17, 2013
121. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Bul I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss H-P, Speth R, Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 100: 8258-8263, 2003
122. Santos RAS, Krieger EM, Greene LJ. An improved fluorometric assay of rat serum and plasma converting enzyme. Hypertension 7: 244-252, 1985
123. Schechter NM, Irani AA, Sprows JL, Abernethy J, Winstroub BU, Schwartz LB. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell. J Immunol 145: 2652-2661, 1990
124. Schuijt MP, van Kats JP, de ZS, Duncker DJ, Verdouw PD, Schalekamp MA, Danser AH. Cardiac interstitial fluid levels of angiotensin I and II in the pig. J Hypertens 17: 1885-1891, 1999
125. Schulz A, Jankowski J, Zidek W, Jankowski V. Absolute quantification of endogenous angiotensin II levels in human plasma using ESILC- MS/MS. Clin Proteomics 11: 37, 2014
126. Semaan W, Desbiens L, Houde M, Labonte J, Gagnon H, Yamamoto D, Takai S, Laidlaw T, Bkaily G, Schwertani A, Pejler G, Levesque C, Desjardins R, Day R, D’Orleans-Juste P. Chymase inhibitorsensitive synthesis of endothelin-1 (1-31) by recombinant mouse mast cell protease 4 and human chymase. Biochem Pharmacol 94: 91-100, 2015
127. Senanayake PD, Moriguchi A, Kumagai H, Ganten D, Ferrario CM, Brosnihan KB. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides 15: 919-926, 1994
128. Senanayake PS, Smeby RR, Martins AS, Moriguchi A, Kumagai H, Ganten D, Brosnihan KB. Adrenal, kidney, and heart angiotensins in female murine Ren-2 transfected hypertensive rats. Peptides 19: 1685-1694, 1998
129. Shaltout HA, Westwood B, Averill DB, Ferrario CM, Figueroa J, Diz DI, Rose JC, Chappell MC. Angiotensin metabolism in renal proximal tubules, urine and serum of sheep: Evidence for ACE2-dependent processing of Angiotensin II. Am J Physiol Renal Physiol 292: F82-F91, 2007
130. Shao W, Seth DM, Navar LG. Augmentation of endogenous intrarenal angiotensin II levels in Val5-Ang II-infused rats. Am J Physiol Renal Physiol 296: F1067-F1071, 2009
131. Shi Y, Lo CS, Padda R, Abdo S, Chenier I, Filep JG, Ingelfinger JR, Zhang SL, Chan JS. Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice. Clin Sci (Lond) 128: 649-663, 2015
132. Singh VP, Le B, Bhat VB, Baker KM, Kumar R. High-glucoseinduced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytes. Am J Physiol Heart Circ Physiol 293: H939-H948, 2007
133. Suski M, Gebska A, Olszanecki R, Stachowicz A, Uracz D, Madej J, Korbut R. Influence of atorvastatin on angiotensin I metabolism in resting and TNF-alpha -activated rat vascular smooth muscle cells. J Renin Angiotensin Aldosterone Syst 15: 378-383, 2014
134. Te RL, van Esch JH, Roks AJ, van den Meiracker AH, Danser AH. Hypertension: renin-angiotensin-aldosterone system alterations. Circ Res 116: 960-975, 2015
135. Tenorio-Lopez FA, Zarco-Olvera G, Sanchez-Mendoza A, Rosas-Peralta M, Pastelin-Hernandez G, Del Valle-Mondragon L. Simultaneous determination of angiotensins II and 1-7 by capillary zone electrophoresis in plasma and urine from hypertensive rats. Talanta 80: 1702-1712, 2010
136. Tikellis C, Bialkowski K, Pete J, Sheehy K, Su Q, Johnston C, Cooper M, Thomas M. ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes. Diabetes 57: 1018-1025, 2008
137. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275: 33238-33243, 2000
138. Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 265: 22348-22357, 1990
139. Van den Heuvel M, Batenburg WW, Jainandunsing S, Garrelds IM, van Gool JM, Feelders RA, van den Meiracker AH, Danser AH. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of reninangiotensin- aldosterone system blockade in the kidney. J Hypertens 29: 2147-2155, 2011
140. Van Kats JP, Schalekamp MA, Verdouw PD, Duncker DJ, Danser AH. Intrarenal angiotensin II: interstitial and cellular levels and site of production. Kidney Int 60: 2311-2317, 2001
141. Vidotti DB, Casarini DE, Cristovam PC, Leite CA, Schor N, Boim MA. High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells. Am J Physiol Renal Physiol 286: F1039-F1045, 2004
142. Wanka H, Kessler N, Ellmer J, Endlich N, Peters BS, Clausmeyer S, Peters J. Cytosolic renin is targeted to mitochondria and induces apoptosis in H9c2 rat cardiomyoblasts. J Cell Mol Med 13: 2926-2937, 2009
143. Westwood BM, Chappell MC. Divergent pathways for the angiotensin- (1-12) metabolism in the rat circulation and kidney. Peptides 35: 190-195, 2012
144. Wilson BA, Cruz-Diaz N, Marshall AC, Pirro NT, Su Y, Gwathmey TM, Rose JC, Chappell MC. An angiotensin-(1-7) peptidase in the kidney cortex, proximal tubules, and human HK-2 epithelial cells that is distinct from insulin-degrading enzyme. Am J Physiol Renal Physiol 308: F594-F601, 2015
145. Wilson BA, Marshall AC, Alzayadneh EM, Chappell MC. The ins and outs of angiotensin processing within the kidney. Am J Physiol Regul Integr Comp Physiol 307: R487-R489, 2014
146. Wintroub BU, Schechter NB, Lazarus GS, Kaempfer CE, Schwartz LB. Angiotensin I conversion by human rat chymotryptic proteinases. J Invest Dermatol 83: 336-339, 1984
147. Wysocki J, Ye M, Batlle D. Plasma and kidney angiotensin peptides: importance of the aminopeptidase A/angiotensin III axis. Am J Hypertens 28: 1418-1426, 2015
148. Yamaleyeva LM, Gilliam-Davis S, Almeida I, Brosnihan KB, Lindsey SH, Chappell MC. Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2. Lewis rats with early-onset diabetes. Am J Physiol Renal Physiol 302: F1374-F1384, 2012
149. Yang R, Smolders I, Vanderheyden P, Demaegdt H, Van Eeckhaut A, Vauquelin G, Lukazuk A, Tourwe D, Chai SY, Albiston AL, Nahmias C, Walther T, Dupont AG. Pressor and renal hemodynamic effects of the novel angiotensin A peptide are AT1a-receptor dependent. Hypertension 57: 956-964, 2011
150. Yang R, Walther T, Gembardt F, Smolders I, Vanderheyden P, Albiston AL, Chai SY, Dupont AG. Renal vasoconstrictor and pressor responses to angiotensin IV in mice are AT1a-receptor mediated. J Hypertens 28: 487-494, 2010
151. Zhuo JL, Li XC. New insights and perspectives on intrarenal reninangiotensin system: focus on intracrine/intracellular angiotensin II. Peptides 32: 1551-1565, 2011
152. Zisman LS, Keller RS, Weaver B, Lin Q, Speth R, Bristow MR, Canver CC. Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensinconverting enzyme homologue ACE2. Circulation 108: 1707-1712, 2003